Table 1:

Baseline patient characteristics according to antiplatelet resistance status

Total (N = 338)Abnormal ARU (n = 32)P ValueaAbnormal PRU (n = 105)P Valuea
Clinical
    Age (≥65 yr)204 (60.4%)14 (43.8%).06133 (31.4%).433
    Sex (female)225 (66.6%)23 (71.9%).56083 (79.0%).001b
    Diabetes23 (6.8%)7 (21.9%).003b11 (10.5%).100
    Hypertension146 (43.2%)16 (50.0%).45648 (45.7%).554
    Hyperlipidemia53 (15.7%)5 (15.6%)1.00012 (11.4%).196
    Smoking59 (17.5%)5 (15.6%).81620 (19.0%).643
    TIA or stroke history16 (4.7%)3 (9.4%).3813 (2.9%).408
Procedure
    Dome size of aneurysm ≥7 mm75 (22.2%)11 (34.4%).11428 (26.7%).204
    Location of aneurysm
        ICA198 (58.6%)18 (56.3%).636c62 (59.0%).588c
        MCA80 (23.7%)11 (34.4%)20 (19.0%)
        ACA28 (8.3%)1 (3.1%)12 (11.4%)
        Posterior circulation32 (9.5%)2 (6.3%)11 (10.5%)
Technique
    Assist with stent149 (44.1%)14 (43.8%)1.00045 (42.9%).813
    Double catheter116 (34.3%)14 (43.8%).24642 (40.0%).173
    Incomplete occlusion48 (14.2%)4 (12.5%).80418 (17.1%).315
    Thrombus formation5 (1.5%)2 (6.3%).0732 (1.9%)1.000
    Mean No. of angiograms ± SD6.87 ± 2.346.53 ± 1.93.3867.17 ± 2.36.115
  • Note:—ACA indicates anterior cerebral artery.

  • a P value was obtained by comparing patients with normal response with a χ2, Fischer exact, or Student t test for each variable.

  • b Significant.

  • c These values were obtained by comparing ICA versus MCA, ACA, or posterior circulation with linear-by-linear association.